Controlled-release propranolol formulations comprise a core comprising a pharmaceutically
acceptable propranolol salt and an inert core; and a coating disposed on the core, the …

Controlled-release propranolol formulations comprise a core comprising a pharmaceutically
acceptable propranolol salt and an inert core; and a coating disposed on the core, the …

US20060099258A1 - Propranolol formulations - Google Patents US20060099258A1 -
Propranolol formulations - Google Patents Propranolol formulations Download PDF Info …

A constant order release rate solid oral dosage formulation of propranolol or a
pharmaceutically acceptable salt thereof, said formulation comprising: a therapeutically …

3,184,386 A 5/1965 Stephenson 3,558,768 A 1/1971 Klippel 3,885,026 A 5, 1975
Heinemann et al. 4,078,051 A 3, 1978 Pomotet al. 4,138.475 A* 2/1979 McAinsh et …

A method of providing a patient suffering from cardiac arrhythmia with a sustained dosage of
propranolol over a prolonged period of time comprises orally administering to the patient a …

A sustained absorption propranolol-containing pellet for oral administration comprises a
core of propranolol or a pharmaceutically acceptable salt thereof and an organic acid …

(57) ABSTRACT A unit dosage form, such as a capsule or the like for delivering drugs into
the body in a sustained release fashion similar to that produced by INDERAL® LA indicated …

The present invention relates to compositions and methods of treating human Subjects with
a beta-adrenergic receptor blocking agent (“beta-blocker) provided in a time-sus tained …

(57) ABSTRACT A unit dosage form, Such as a capsule or the like for delivering drugs into
the body in a circadian release fashion, is comprising of one or more populations of …